BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17952831)

  • 1. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
    Calabro P; Yeh ET
    Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of resistin in obesity-induced insulin resistance.
    Haluzik M; Haluzikova D
    Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of resistin as a regulator of inflammation: Implications for various human pathologies.
    Filková M; Haluzík M; Gay S; Senolt L
    Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue: a regulator of inflammation.
    Juge-Aubry CE; Henrichot E; Meier CA
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):547-66. PubMed ID: 16311216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.
    Ferrante AW
    J Intern Med; 2007 Oct; 262(4):408-14. PubMed ID: 17875176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.
    Koerner A; Kratzsch J; Kiess W
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):525-46. PubMed ID: 16311215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current biology of resistin.
    Steppan CM; Lazar MA
    J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adipocytokins, obesity and development of type 2 diabetes].
    Lacquemant C; Vasseur F; Leprêtre F; Froguel P
    Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue macrophages.
    Zeyda M; Stulnig TM
    Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of resistin in inflammation and inflammation-related diseases.
    Pang SS; Le YY
    Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking resistin, inflammation, and cardiometabolic diseases.
    Park HK; Kwak MK; Kim HJ; Ahima RS
    Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflamed adipose tissue, insulin resistance and vascular injury.
    Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U
    Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
    Tilg H; Moschen AR
    Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.